Drug Safety Issues in Therapy COVID-19-Reference-Cited by-同舟云学术

Drug Safety Issues in Therapy COVID-19

Published:2020-05-31 Issue:3 Volume:10 Page:165-187
ISSN:2411-6564
Container-title:The Russian Archives of Internal Medicine
language:
Short-container-title:Arhivʺ vnutrennej mediciny

Author:

Levitova D. G.¹^ORCID,Gracheva S. A.¹^ORCID,Samoylov A. S.²,Udalov U. D.²^ORCID,Praskurnichiy E. A.³^ORCID,Parinov O. V.¹^ORCID

Affiliation:

1. State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

2. State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Medico-biological University of Innovation and Continuing Education State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

3. Medico-biological University of Innovation and Continuing Education State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Publisher

Synapse, LLC

Subject

General Medicine

Reference80 articles.

1. Colson P., Rolain J.M., Lagier J.C. et al. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020;55(4):105932. doi: 10.1016/j.ijantimicag.2020.105932.

2. Dayer M.R., Taleb-Gassabi S., Dayer M.S. Lopinavir; A Potent Drug against Coronavirus Infection: Insight from Molecular Docking Study. Arch Clin Infect Dis. 2017;12(4):e13823. doi: 10.5812/archcid.13823.

3. De Meyer S., Bojkova D., Cinatl J. et al. Lack of Antiviral Activity of Darunavir against SARS-CoV-2. 2020. 08 Apr. Preprint from medRxiv. doi: 10.1101/2020.04.03.20052548.

4. Muralidharan N., Sakthivel R., Velmurugan D. et al. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19. J Biomol Struct Dyn. 2020. Apr 06. Preprint. doi: 10.1080/07391102.2020.1752802.

5. Li G., De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature reviews drug discovery. 2020;19(3):149-150. doi:10.1038/d41573-020-00016-0.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver injury in COVID-19: two clinical cases;Almanac of Clinical Medicine;2020-12-29